| __timestamp | Sarepta Therapeutics, Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 49315000 | 2999000 |
| Thursday, January 1, 2015 | 75043000 | 10393000 |
| Friday, January 1, 2016 | 83749000 | 15994000 |
| Sunday, January 1, 2017 | 122682000 | 26975000 |
| Monday, January 1, 2018 | 207761000 | 39509000 |
| Tuesday, January 1, 2019 | 284812000 | 48869000 |
| Wednesday, January 1, 2020 | 317875000 | 42510000 |
| Friday, January 1, 2021 | 282660000 | 46105000 |
| Saturday, January 1, 2022 | 451421000 | 50513000 |
| Sunday, January 1, 2023 | 481871000 | 51292000 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, managing operational costs is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Sarepta Therapeutics, Inc. and Wave Life Sciences Ltd. from 2014 to 2023.
Sarepta Therapeutics has seen a dramatic increase in SG&A expenses, growing nearly tenfold from 2014 to 2023. This reflects their aggressive expansion and investment in marketing and administration. In contrast, Wave Life Sciences has maintained a more conservative growth, with expenses increasing by approximately 70% over the same period.
Sarepta's higher SG&A expenses could indicate a robust strategy to capture market share, while Wave's steadier approach may suggest a focus on sustainable growth. Investors and stakeholders should consider these trends when evaluating the companies' long-term potential.
Johnson & Johnson or Sarepta Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Merck & Co., Inc. and Sarepta Therapeutics, Inc.
Comparing SG&A Expenses: AstraZeneca PLC vs Wave Life Sciences Ltd. Trends and Insights
Operational Costs Compared: SG&A Analysis of Gilead Sciences, Inc. and Wave Life Sciences Ltd.
Teva Pharmaceutical Industries Limited and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Intra-Cellular Therapies, Inc. and Wave Life Sciences Ltd.
Selling, General, and Administrative Costs: Sarepta Therapeutics, Inc. vs Ascendis Pharma A/S
Sarepta Therapeutics, Inc. or Opthea Limited: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Sarepta Therapeutics, Inc. vs Axsome Therapeutics, Inc. Trends and Insights
Blueprint Medicines Corporation vs Wave Life Sciences Ltd.: SG&A Expense Trends
Corcept Therapeutics Incorporated and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared
Axsome Therapeutics, Inc. and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared